Petition Seeks Mass Tort for Levaquin, Cipro, Avelox Lawsuits in Pennsylvania

As a growing number of Levaquin lawsuits, Cipro lawsuits and Avelox lawsuits continue to be filed in the Pennsylvania state court system, each involving similar allegations that users of the popular antibiotics developed peripheral neuropathy, a request has been filed to establish “mass tort” proceedings in the state.

A petition was filed last week by a group of 32 plaintiffs who have brought peripheral neuropathy cases against the makers of Levaquin, Cipro and Avelox, seeking to have all lawsuits pending in Pennsylvania state court centralized before one judge in Philadelphia for pretrial proceedings.

Each of the complaints raise nearly identical allegations, indicating that manufacturers of fluoroquinolone-based antibiotics failed to adequately warn about the risk that users may suffer severe and long-term nerve damage, withholding warnings that the symptoms may continue long after the medications are no longer used.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The request was filed with Philadelphia Administrative Judge Kevin M. Dougherty, according to a report by The Legal Intelligencer, seeking to centralize the claims as part of a Levaquin, Cipro and Avelox Mass Tort in the Philadelphia Court of Common pleas, which would reduce duplicative discovery into common issues presented in the cases, avoid contradictory rulings from different judges and serve the convenience of the parties, witnesses and the judicial system.

Similar centralized proceedings have already been established for Levaquin, Cipro and Avelox cases pending in the federal court system, where complaints filed nationwide have been centralized since August before U.S. District Judge John R. Tunheim in the District of Minnesota, as part of a federal Multi-District Litigation, or MDL.

There are currently over 225 cases filed in U.S. District Courts nationwide centralized before Judge Tunheim, and the number of cases is expected to continue to grow as antibiotic peripheral neuropathy lawyers continue to review and file complaints for former users of Levaquin, Cipro and Avelox. Many estimates suggest that there will ultimately be several thousand cases filed nationwide.

About Antibiotic Peripheral Neuropathy Risks

The Levaquin, Cipro and Avelox mass tort litigation has emerged since the FDA required new warnings for all fluoroquinolone-based antibiotics in August 2013.

While prior warnings provided with the drugs indicated that some users experienced nerve damage, the manufacturers have suggested that the problems were rare and often resolved when the antibiotic was no longer used.

After reviewing adverse event reports and available data, the FDA required the makers of all fluoroquinolones to provide information about the long-term risk of peripheral neuropathy from the antibiotics, indicating problems may last for months or years after an individual stops taking the drug.

Peripheral neuropathy involves damage to the nerves that may impair sensation, movement and other aspects of health. This may leave users with persistent pain, burning, tingling, numbness, weakness and sensitivity to light touches, temperature and motion in the arms and legs, as well as other problems that cause a major disruption to daily activities.

Plaintiffs allege that the makers of Levaquin, Avelox and Cipro should have provided these warnings years ago, noting that the first indication of a possible link between long-term peripheral neuropathy and fluoroquinolone antibiotics came in a study published in 2001.

If adequate warnings had been provided about the risk of permanent neuropathy problems, plaintiffs indicate that they may have avoided painful and debilitating injuries.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted 2 days ago)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 4 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.